3,515 Stryker Corporation $SYK Shares Sold by Fishman Jay A Ltd. MI

Fishman Jay A Ltd. MI decreased its position in shares of Stryker Corporation (NYSE:SYK) by 4.7% in the third quarter, HoldingsChannel reports. The firm owned 70,773 shares of the medical technology company’s stock after selling 3,515 shares during the quarter. Stryker accounts for 1.6% of Fishman Jay A Ltd. MI’s portfolio, making the stock its 16th biggest position. Fishman Jay A Ltd. MI’s holdings in Stryker were worth $19,490,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of SYK. Bank of America Corp DE acquired a new stake in Stryker during the 2nd quarter valued at approximately $1,404,284,000. Legal & General Group Plc acquired a new stake in shares of Stryker in the second quarter worth $707,212,000. Jupiter Topco LLC purchased a new position in shares of Stryker during the second quarter worth $681,581,000. Corient Private Wealth LP purchased a new position in shares of Stryker during the second quarter worth $323,035,000. Finally, Flossbach Von Storch SE acquired a new stake in Stryker during the 2nd quarter worth about $464,506,000. Hedge funds and other institutional investors own 77.09% of the company’s stock.

Stryker Stock Down 1.5%

NYSE SYK opened at $301.59 on Wednesday. The stock has a 50-day moving average of $294.70 and a 200 day moving average of $325.45. Stryker Corporation has a twelve month low of $267.00 and a twelve month high of $389.33.

Stryker (NYSE:SYK) last posted its quarterly earnings data on Thursday, July 30th. The medical technology company reported $3.69 EPS for the quarter, beating analysts’ consensus estimates of $3.49 by $0.20. The business had revenue of $6.59 billion during the quarter, compared to analysts’ expectations of $6.58 billion. The firm’s quarterly revenue was up 9.4% compared to the same quarter last year. During the same quarter last year, the firm earned $3.13 earnings per share. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. Analysts predict that Stryker Corporation will post 14.93 earnings per share for the current year.

Stryker Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be paid a $0.88 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $3.52 dividend on an annualized basis and a yield of 1.2%.

Insider Buying and Selling

In other Stryker news, insider Debra King sold 826 shares of the stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $336.30, for a total transaction of $277,783.80. Following the transaction, the insider directly owned 6,210 shares of the company’s stock, valued at $2,088,423. This trade represents a 11.74% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Ronda Stryker sold 50,000 shares of Stryker stock in a transaction dated Wednesday, August 19th. The shares were sold at an average price of $340.10, for a total transaction of $17,005,000.00. Following the completion of the sale, the director owned 2,251,375 shares in the company, valued at approximately $765,692,637.50. This trade represents a 2.17% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 351,267 shares of company stock valued at $118,197,701. 4.60% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

SYK has been the subject of several analyst reports. Wolfe Research cut Stryker from an “outperform” rating to a “peer perform” rating in a report on Thursday, August 13th. Citigroup reduced their price target on Stryker from $399.00 to $360.00 and set a “buy” rating for the company in a research report on Thursday, September 10th. Stifel Nicolaus decreased their price target on Stryker from $360.00 to $330.00 and set a “buy” rating for the company in a report on Wednesday, September 30th. BMO Capital Markets reaffirmed an “outperform” rating and set a $317.00 price objective on shares of Stryker in a research note on Wednesday, September 9th. Finally, Argus set a $370.00 target price on shares of Stryker in a research note on Thursday, July 9th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Stryker currently has a consensus rating of “Moderate Buy” and an average target price of $369.00.

Stryker Company Profile

Stryker Corporation (NYSE: SYK) is a global medical technology company that develops and manufactures products used by healthcare providers in hospitals, surgical centers and other clinical settings. Its offerings are designed to support orthopaedic procedures, surgery, emergency care, neurovascular treatment and patient handling.

The company’s product portfolio includes orthopaedic implants and instruments, products for trauma and spine procedures, surgical equipment, endoscopy systems, patient beds and stretchers, emergency medical equipment, and neurovascular devices used in the treatment of conditions such as stroke.